Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in southwestern Alaska

Clinical and Vaccine Immunology

Volumn 13, Issue 6, 2006, Pages 620-626

  Baggett, Henry C ^a,b   Hennessy, Thomas W ^a   Bulkow, Lisa ^a   Romero Steiner, Sandra ^a   Hurlburt, Debra ^a   Holder, Patricia ^a   Parkinson, Alan J ^a   Singleton, Rosalyn J ^a   Levine, Orin ^a   Carlone, George M ^a   Butler, Jay C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; OLIGOSACCHARIDE;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SERUM BACTERICIDAL ACTIVITY; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; ALASKA; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; BACTERIAL VACCINES; CARRIER STATE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; MALE; RISK FACTORS; RURAL POPULATION; TIME FACTORS; VACCINES, CONJUGATE;

EID: 33745830161     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00077-06     Document Type: Article

References (37)

1. Barbosa-Cesnik, C., R. S. Farjo, M. Patel, J. Gilsdort, S. I. McCoy, M. M. Pettigrew, C. Marrs, and B. Foxman. 2006. Predictors for Haemophilus influenzae colonization, antibiotic resistance and for sharing an identical isolate among children attending 16 licensed day-care centers in Michigan. Pediatr. Infect. Dis. J. 25:219-223.
2. Barbour, M. L., R. Booy, D. W. Crook, H. Griffiths, H. M. Chapel, E. R. Moxon, and D. Mayon-White. 1993. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilia influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. Pediatr. Infect. Dis. J. 12:478-484.
3. Barbour, M. L. 1996. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg. Infect. Dis. 3:176-182.
4. Barbour, M. L., R. T. Mahon-White, C. Coles, D. W. Crook, and E. R. Moxon. 1995. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171:93-98.
5. Bisgard, K. M., A. Kao, J. Leake, P. M. Strebel, B. A. Perkins, and M. Wharton. 1998. Haemophilus influenzae invasive disease in the United States, 1994-95: near disappearance of a vaccine-preventable childhood disease. Emerg. Infect. Dis. 4:229-237.
6. Braveman, P., C. Cubbin, K. Marchi, S. Egerter, and G. Chavez. 2001. Measuring socioeconomic status/position in studies of racial/ethnic disparities: maternal and infant health. Public Health Rep. 116:449-463.
7. Bulkow, L. R., R. B. Wainwright, G. W. Letson, S. J. Chang, and J. I. Ward. 1993. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr. Infect. Dis. J. 12:484-492.
8. Centers for Disease Control and Prevention. 1998. Progress toward eliminating Haemophilus influenzae type b disease in children-United States, 1987-1997. Morb. Mortal. Wkly. Rep. 47:993-998.
9. Centers for Disease Control and Prevention. 2003. Vaccination coverage levels among Alaska Native children aged 19-35 months-National Immunization Survey, United States, 2000-2001. Morb. Mortal. Wkly. Rep. 52:710-713.
10. Cochi, S. L., C. V. Broome, and A. W. Hightower. 1985. Immunization of U.S. children with Haemophilus influenzae type b polysaccharide vaccine: a cost-effectiveness model of strategy assessment. JAMA 253:521-529.
11. Dajani, A. S., B. I. Asmar, and M. C. Thirumoorthi. 1979. Systemic Haemophilus influenzae disease: an overview. J. Pediatr. 92:355-364.
12. Fernandez, J., S. Balter, J. Feris, E. Gómez, Z. Garib, P. L. Castellanos, J. Sánchez, S. Romero-Steiner, and O. S. Levine. 2000. Randomized trial of the immunogenicity of fractional-dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am. J. Trop. Med. Hyg. 62:485-490.
13. Fernandez, J., O. S. Levine, J. Sanchez, S. Balter, L. LaClaire, J. Feris, and S. Romero-Steiner. 2000. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. J. Infect. Dis. 182:1553-1556.
14. Galil, K., R. Singleton, O. Levine, M. A. Fitzgerald, L. Bulkow, M. Getty, B. A. Perkins, and A. Parkinson. 1999. Reemergence of invasive Haemophilus influenzae type B disease in a well-vaccinated population in remote Alaska. J. Infect. Dis. 179:101-106.
15. Goldblatt, D., A. R. Vaz, and E. Miller. 1998. Antibody avidity as a surrogate marker of successful priming to Haemophilus influenzae type b conjugate vaccines following infant immunization. J. Infect. Dis. 177:1112-1115.
16. Goldsby, R. A., T. J. Kindt, and B. A. Osborne. 2000. Immunoglobulins: structure and function, p. 83-113. In R. A. Goldsby, T. J. Kindt, and B. A. Osborne (ed.), Kuby immunology, 4th ed. W. H. Freeman and Company, New York, N.Y.
17. Hall, D. B., M. K. W. Lum, L. R. Knutson, W. L. Heward, and J. I. Ward. 1987. Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska. Am. J. Epidemiol. 126:1190-1197.
18. Heath, P. T., R. Booy, H. J. Azzopardi, M. P. Slack, J. Bowen-Morris, H. Griffiths, M. E. Ramsay, J. J. Deeks, and E. R. Moxon. 2000. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 284:2334-2340.
19. Kauppi, M., J. Eskola, and H. Käyhty. 1995. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr. Infect. Dis. J. 14:286-294.
20. Käyhty, H., H. Peltola, V. Karanko, and P. H. Mäkelä. 1983. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 147:1100.
21. Madore, D. V., P. Anderson, B. D. Baxter, G. M. Carlone, K. M. Edwards, R. G. Hamilton, P. Holder, H. Kayhty, D. C. Phipps, C. C. Peeters, R. Schneerson, G. R. Siber, J. I. Ward, and C. E. Frasch. 1996. Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 3:84-88.
22. Madore, D. V., C. L. Johnson, D. C. Phipps, M. G. Myers, R. Eby, and D. H. Smith. 1990. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics 86:527-534.
23. Michaels, R. H., F. E. Stonebraker, and J. B. Robbins. 1975. Use of anti-serum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr. Res. 9:513-516.
24. Mohle-Boetani, J. C., G. Ajello, E. Breneman, K. A. Deaver, C. Harvey, B. D. Plikaytis, M. M. Farley, D. S. Stephens, and J. D. Wenger. 1993. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr. Infect. Dis. J. 12:589-593.
25. Murphy, T. V., P. Pastor, R. Medley, M. T. Osterholm, and D. M. Granoff. 1993. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 122:517-523.
26. Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.
27. Plikaytis, B., P. F. Holder, L. B. Pais, S. E. Maslanka, L. L. Gheesling, and G. M. Carlone. 1994. Determination of parallelism and nonparallelism in bioassay dilution curves. J. Clin. Microbiol. 32:2441-2447.
28. Reid, R., M. Santosham, J. Croll, C. Thompson, W. Newcomer, and G. R. Siber. 1993. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine. Pediatr. Infect. Dis. J. 12:812-815.
29. Romero-Steiner, S., J. Fernandez, C. Biltoft, M. E. Wohl, J. Feris, S. Balter, O. S. Levine, and G. M. Carlone. 2001. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus conjugate). Clin. Diagn. Lab. Immunol. 8:1115-1119.
30. Romero-Steiner, S., P. F. Holder, P. Gomez de Leon, W. Spear, T. W. Hennessy, and G. M. Carlone. 2005. Avidity determinations for Haemophilus influenzae type b anti-polyribosylribitol phosphate antibodies. Clin. Diagn. Lab. Immunol. 12:1029-1035.
31. Santosham, M. 2000. Can Haemophilus influenzae type b disease be eliminated from the United States? J. Pediatr. 137:295-298.
32. Schlesinger, Y., D. M. Granoff, and the Vaccine Study Group. 1992. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 267:1489-1494.
33. Schneerson, R., and J. B. Robbins. 1975. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N. Engl. J. Med. 292:1093-1096.
34. Singleton, R., L. R. Bulkow, O. S. Levine, J. C. Butler, T. W. Hennessy, and A. Parkinson. 2000. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. J. Pediatr. 137:313-320.
35. Takala, A. K., J. Eskola, M. Leinonen, H. Kayhty, A. Nissinen, E. Pekkanen, and P. H. Makela. 1991. Reduction of oropharyngeal carriage of Haemophilus influenze type b (HIB) in children immunized with Hib conjugate vaccine. J. Infect. Dis. 164:982-986.
36. van Den Hof, S., H. E. de Melker, G. A. Berbers, P. H. van Der Kraak, and M. A. Spaendonck. 2001. Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination. Clin. Infect. Dis. 32:2-8.
37. Ward, J. I., M. K. Lum, D. B. Hall, D. R. Silimperi, and T. R. Bender. 1986. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J. Infect. Dis. 153:17-26.